Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective

The incidence of breast ductal carcinoma in situ (DCIS) in the USA exceeds that of other countries. This cannot be explained entirely by the frequency of mammographic screening in the USA and may result from differences in the interpretation of mammograms and/or the frequency with which biopsies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Anjali S, Bhatia, Vinona, Henderson, I Craig
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410763/
https://www.ncbi.nlm.nih.gov/pubmed/16457703
http://dx.doi.org/10.1186/bcr1346
_version_ 1782127068589326336
author Kumar, Anjali S
Bhatia, Vinona
Henderson, I Craig
author_facet Kumar, Anjali S
Bhatia, Vinona
Henderson, I Craig
author_sort Kumar, Anjali S
collection PubMed
description The incidence of breast ductal carcinoma in situ (DCIS) in the USA exceeds that of other countries. This cannot be explained entirely by the frequency of mammographic screening in the USA and may result from differences in the interpretation of mammograms and/or the frequency with which biopsies are obtained. Although the percentage of DCIS patients treated with mastectomy has decreased, the absolute number is unchanged and the use of lumpectomy with whole-breast radiotherapy has increased in inverse proportion to the decrease in mastectomy. Treatment of DCIS with tamoxifen is still limited.
format Text
id pubmed-1410763
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14107632006-03-24 Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective Kumar, Anjali S Bhatia, Vinona Henderson, I Craig Breast Cancer Res Review The incidence of breast ductal carcinoma in situ (DCIS) in the USA exceeds that of other countries. This cannot be explained entirely by the frequency of mammographic screening in the USA and may result from differences in the interpretation of mammograms and/or the frequency with which biopsies are obtained. Although the percentage of DCIS patients treated with mastectomy has decreased, the absolute number is unchanged and the use of lumpectomy with whole-breast radiotherapy has increased in inverse proportion to the decrease in mastectomy. Treatment of DCIS with tamoxifen is still limited. BioMed Central 2005 2005-11-11 /pmc/articles/PMC1410763/ /pubmed/16457703 http://dx.doi.org/10.1186/bcr1346 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Review
Kumar, Anjali S
Bhatia, Vinona
Henderson, I Craig
Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title_full Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title_fullStr Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title_full_unstemmed Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title_short Overdiagnosis and overtreatment of breast cancer: Rates of ductal carcinoma in situ: a US perspective
title_sort overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a us perspective
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410763/
https://www.ncbi.nlm.nih.gov/pubmed/16457703
http://dx.doi.org/10.1186/bcr1346
work_keys_str_mv AT kumaranjalis overdiagnosisandovertreatmentofbreastcancerratesofductalcarcinomainsituausperspective
AT bhatiavinona overdiagnosisandovertreatmentofbreastcancerratesofductalcarcinomainsituausperspective
AT hendersonicraig overdiagnosisandovertreatmentofbreastcancerratesofductalcarcinomainsituausperspective

Ejemplares similares